← All trials
NCT03376659
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 8, 2018
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 54
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Georgetown UniversityLead sponsor
- Bavarian NordicCollaborator
- Emory UniversityCollaborator
- George Mason UniversityCollaborator
- Indiana UniversityCollaborator
- Johns Hopkins UniversityStudy chair
- Mayo ClinicCollaborator
- National Cancer Institute (NCI)Collaborator
- Thomas Jefferson UniversityCollaborator
- MedImmuneCollaborator
- Johns Hopkins UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.